Giuseppe Spadola

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

Anna Maria Di Giacomo, Paolo A. Ascierto, Paola Queirolo et al. · Annals of Oncology · 2014 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17

Prognostic significance of hematological profiles in melanoma patients

Sara Gandini, Pier Francesco Ferrucci, Edoardo Botteri et al. · International Journal of Cancer · 2016 · 45 citations · Full text

Medicine, Hematology, Oncology +16

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup

William Bruno, Lorenza Pastorino, Paola Ghiorzo et al. · Journal of the American Academy of Dermatology · 2016 · 40 citations · Full text

Medicine, Dermatology, Oncology +17

Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1

Lorenza Pastorino, Virginia Andreotti, Bruna Dalmasso et al. · Cancers · 2020 · 36 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Azithromycin: A new therapeutical strategy for acne in adolescents

Federico Bardazzi, Francesco Savoia, Gianluca Parente et al. · Dermatology Online Journal · 2007 · 34 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14